vTv Therapeutics (PPAR-delta program) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

vTv Therapeutics (PPAR-delta program) General Information

Description

Research, development and commercialization rights of peroxisome proliferator-activated receptor delta. The peroxisome proliferator-activated receptor delta program provides lowering of low-density lipoprotein cholesterol and triglycerides in animal models and humans, with a significant increase in high-density lipoprotein cholesterol and has an anti-diabetic effect in several animal models of type 2 diabetes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • High Point, NC
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Reneo Pharmaceuticals
Vertical(s)
LOHAS & Wellness
Corporate Office
  • High Point, NC
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

vTv Therapeutics (PPAR-delta program) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore vTv Therapeutics (PPAR-delta program)‘s full profile, request access.

Request a free trial

vTv Therapeutics (PPAR-delta program) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore vTv Therapeutics (PPAR-delta program)‘s full profile, request access.

Request a free trial

vTv Therapeutics (PPAR-delta program) FAQs

  • Where is vTv Therapeutics (PPAR-delta program) headquartered?

    vTv Therapeutics (PPAR-delta program) is headquartered in High Point, NC.

  • What industry is vTv Therapeutics (PPAR-delta program) in?

    vTv Therapeutics (PPAR-delta program)’s primary industry is Buildings and Property.

  • Is vTv Therapeutics (PPAR-delta program) a private or public company?

    vTv Therapeutics (PPAR-delta program) is a Private company.

  • What is vTv Therapeutics (PPAR-delta program)’s current revenue?

    The current revenue for vTv Therapeutics (PPAR-delta program) is .

  • Who are vTv Therapeutics (PPAR-delta program)’s investors?

    vTv Therapeutics has invested in vTv Therapeutics (PPAR-delta program).

  • When was vTv Therapeutics (PPAR-delta program) acquired?

    vTv Therapeutics (PPAR-delta program) was acquired on 21-Dec-2017.

  • Who acquired vTv Therapeutics (PPAR-delta program)?

    vTv Therapeutics (PPAR-delta program) was acquired by Reneo Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process